This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Nadim Akhtar, PhD
Principal Scientist Characterization & Control Strategies at AstraZeneca

Profile

Nadim Akhtar has a PhD degree in chemistry from Manchester and has been working for AstraZeneca since 2007. During this time Nadim has worked across different fields including new modalities, advanced drug delivery and predictive science supporting both drug substance and drug product activities. Nadim currently sits in the New Modalities and Parenteral Development (NMPD) function and has been involved with oligonucleotides since 2012, supporting both early and late stage portfolio. Nadim has authored several regulatory filing involving small molecules, oligonucleotides and nanomedicines.

Agenda Sessions

  • Analytical Strategies for Oligonucleotides

    12:15
  • Drug Product Development Strategies for Oligonucleotides and Peptides

    11:15
  • Formulations and Process Development for Terminal Sterilization of Oligonucleotide Drug

    On Demand
  • Formulations and Process Development for Terminal Sterilization of Oligonucleotide Drug

    On Demand
  • SESSION NAME: Analytical Strategies for Oligonucleotides SESSION CHAIRS & SPEAKERS BELOW:

    On Demand
  • SESSION NAME: Drug Product Development Strategies for Oligonucleotides and Peptides SESSION CHAIRS & SPEAKERS BELOW:

    On Demand
  • SESSION NAME: Drug Product Development Strategies for Oligonucleotides and Peptides SESSION CHAIRS & SPEAKERS BELOW:

    On Demand